Filana Therapeutics, Inc

FLNANASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

48.3M

on 2026-06-30, from 43.2M on 2024-03-31 10-Q ↗

Newest

$200.0M

S-3 of 2025-11-13. Sales under the at-the-market programme filed with it are not stated apart. S-3 ↗

$50.0M

Cantor Fitzgerald, agreement of 2025-11-12. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗

Warrants

None

Priced warrants: none left. 10-K ↗

Cash

Four quarters of operating cash flow to 2026-06-30 are not all on file.

Raised: 1 of its filings are not read yet.